首页> 中文期刊> 《世界中医药》 >主动监测在中药注射剂上市后临床安全性评价的应用及范例

主动监测在中药注射剂上市后临床安全性评价的应用及范例

         

摘要

Objective:To explore and evaluate the post-marketing safety evaluation methods with the example of three heat-clearing and detoxifying injections of traditional Chinese medicine.Methods:We monitored patients taken the above injections based on active surveil-lance methods.It is a prospective,multi-center,large sample and nested case-controlled design,to investigate the incidence,character-istics and influencing factors of adverse reaction (ADR).Results:Among 10,029 patients monitored,26 patients had ADR,5 of them experienced allergic reactions.IgE of the 5 patients who had allergic reactions was elevated.Conclusion:The overall ADR incidence rate is 0.26% (0.1% ~1%)and allergic reactions are probably mediated by IgE.%目的:以三种清热解毒类中药注射剂为例,为其上市后临床安全性评价及方法学研究提供范例。方法:基于前瞻性、多中心、大样本主动监测嵌套巢式病例对照设计的方法,监测使用三种中药注射剂的患者,探索不良反应发生率、发生特征及过敏反应可能的影响因素。结果:监测10029例患者,共发生26例 ADR,包括5例过敏反应,经过人体免疫毒理学指标检测,患者的IgE 皆有所升高。结论:基于监测数据计算总体 ADR 发生率为0.26%,属于偶见(0.1%~1%),过敏反应可能由 IgE 介导,这也为此类问题的研究探索了方法学范式。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号